Biomarkers such as alpha-fetoprotein (AFP), vascular endothelial growth factor (VEGF), angiopoietin 2 or c-Kit have been shown to potentially allow for the prognostic stratification of HCC [6]. The gene discussed is AFP; the disease is hepatocellular carcinoma.